|
|
|
|
|
|
|
|
|
|
Previous: DRUG EMPORIUM INC, 10-Q, EX-18, 2000-10-11 |
Next: DRUG EMPORIUM INC, 10-Q, EX-27.2, 2000-10-11 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> MAR-03-2001
<PERIOD-START> FEB-27-2000
<PERIOD-END> AUG-26-2000
<EXCHANGE-RATE> 1
<CASH> 752
<SECURITIES> 0
<RECEIVABLES> 23,927
<ALLOWANCES> 0
<INVENTORY> 187,935
<CURRENT-ASSETS> 214,914
<PP&E> 86,485
<DEPRECIATION> 56,407
<TOTAL-ASSETS> 264,108
<CURRENT-LIABILITIES> 172,758
<BONDS> 59,800
0
0
<COMMON> 1,320
<OTHER-SE> 26,657
<TOTAL-LIABILITY-AND-EQUITY> 264,108
<SALES> 427,847
<TOTAL-REVENUES> 427,847
<CGS> 336,468
<TOTAL-COSTS> 91,915
<OTHER-EXPENSES> (1,934)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 4,979
<INCOME-PRETAX> (3,581)
<INCOME-TAX> (2,504)
<INCOME-CONTINUING> (1,077)
<DISCONTINUED> (20,980)
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (22,057)
<EPS-BASIC> (1.67)
<EPS-DILUTED> (1.67)
</TABLE>
|
|